In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
|Videos|January 9, 2013
Corticosteroids for IBD
Are corticosteroids still the number one drug for inducing clinical remission in IBD?
Advertisement
Are corticosteroids still the number one drug for inducing clinical remission in IBD? Find out in this video.
Advertisement
Related to this article
The gap is not a paperwork inconvenience—it is a cash flow problem with clinical consequences.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
5